CTCF and prostate adenocarcinoma: To evaluate the adaptability of the DARDN sequence feature identification method, we applied it on five other cancer types where cancer-specific CTCF sites were identified in our previous work [4], acute myeloid leukemia (AML), breast invasive carcinoma (BRCA), colorectal cancer (CRC), lung adenocarcinoma (LUAD), and prostate adenocarcinoma (PRAD), using the moderate input sequence length of 10 kbps.